James Bazire
London, ENG NW11AT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses.
Journal: The Journal of infection
Published: July 18, 2025
Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis.
Journal: BMJ neurology open
Published: June 11, 2025
A Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening.
Journal: Viruses
Published: February 11, 2025
Improved Resolution of Influenza Vaccination Responses With High-Throughput Live Virus Microneutralisation.
Journal: Influenza and other respiratory viruses
Published: December 06, 2024
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics.
Journal: Vaccine
Published: December 04, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.
Journal: The Lancet. Infectious diseases
Published: April 11, 2024
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
Journal: Lancet (London, England)
Published: January 05, 2024
Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro.
Journal: Antiviral research
Published: August 23, 2023
Differences in airborne stability of SARS-CoV-2 variants of concern is impacted by alkalinity of surrogates of respiratory aerosol.
Journal: Journal of the Royal Society, Interface
Published: June 21, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026